Searched for
MESSENGER RNA
Could protein 'traffic jams' be the key to understanding aging and Alzheimer's? Here's what Stanford scientists claimStanford University researchers have identified a breakdown in the cell's protein production system as a key factor in brain aging and cogn...- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- Scientists Identify the Main Cause of Sunburns, and Now They Have to Update the TextbooksA groundbreaking study reveals a new cause for sunburn's immediate pain. Scientists now believe damage to RNA, not DNA, triggers the rapid ...
- What is microRNA? Nobel-winning discovery explainedUS scientists Victor Ambros and Gary Ruvkun won the Nobel Prize in Medicine for discovering microRNA, a genetic switch crucial for gene reg...
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...
- Countries which chose Covishield fared better than those that took mRNA vax: Adar PoonawallaCovovax, which is our Novavax product, is proven to be the best against Omicron and Omicron sub variants. It is also the only vaccine from ...
- Cipla invests in Ethris for mRNA-based inhalation therapiesThe investment will facilitate a long-term strategic partnership between Cipla and Ethris for the development of messenger RNA (mRNA)-based...
- Early life experiences can impact our genes later on, even affect longevity, finds new studyThe gene expression 'memory' can persist across the lifespan.
- WHO clears China's CanSino COVID vaccine for emergency useThe CanSino vaccine uses a harmless virus called an adenovirus to deliver the spike protein of the coronavirus into the body, which then pr...
- Covishield offers longer immunity than mRNA jabs, says Adar PoonawallaPoonawalla, ET's Business Leader Of the Year for 2021, was optimistic that final approvals for administering Covovax to children would come...
- Biological E to get mRNA technology from WHO to make COVID-19VaccinesWHO along with its partners will work with the Indian government and BE to develop a roadmap and put in place the necessary training and su...
- Sanofi drops plans for messenger RNA vaccine against virusThe Paris-based company said it will continue to develop another vaccine candidate that is already undergoing late stage human trials. That...
- Biological E signs pact to manufacture Providence vaccineUnder the agreement, Providence will provide the necessary technology transfer for Biological E to manufacture mRNA vaccines in India with ...
- BioNTech to build mRNA manufacturing site in SingaporeThe biotech company said the Singapore production facility will have an estimated annual capacity of several hundred million doses of mRNA-...
- France to recommend mRNA COVID-19 shots as second dose for some after AstraZeneca: MinisterConfidence in the AstraZeneca vaccine has dropped in Europe since a very few, mostly young, recipients of the shot were found to have suffe...
- Pfizer, Moderna COVID-19 vaccines highly effective even after first shot in real-world useThe study by the U.S. Centers for Disease Control and Prevention (CDC) evaluated the vaccines' ability to protect against infection, includ...
- Pfizer, Moderna vaccines may greatly reduce risk of asymptomatic COVID-19 infection, study saysThe Pfizer-BioNTech and Moderna messenger RNA (mRNA) vaccines for COVID-19 are authorised for emergency use in many countries. An mRNA vacc...
- Pfizer/BioNTech's Covid-19 vaccine: How the mRNA technology worksThe UK health secretary, Matt Hancock, tweeted that the NHS stands ready to start vaccinating early next week.
- GSK collaborates with Germany's CureVac, set to take 10% stake for $163 millionBritain's GSK said on Monday it would invest 130 million pounds ($163 million) in German biotech firm CureVac for a 10% stake to work toget...
- New customisable vaccine can fight Ebola, H1NI quickly: ResearchThe vaccines were able to stimulate both arms of the immune system -- a T cell response and an antibody response.
Load More
